DEA schedule
Is piperacillin and tazobactam a controlled substance?
Federal schedule for piperacillin and tazobactam from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Piperacillin and tazobactam is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and piperacillin and tazobactam is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted piperacillin and tazobactam?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 84 prescription listings from 18 labelers, none with a DEA schedule |
| DEA controlled substances list | piperacillin and tazobactam is not on the list |
Piperacillin and Tazobactam NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 0264-3446 | Piperacillin and Tazobactam and Sodium Chloride | injection, solution | 250 mg/50mL; 2 g/50mL | B. Braun Medical Inc. | None |
| 0264-3448 | Piperacillin and Tazobactam and Sodium Chloride | injection, solution | 375 mg/50mL; 3 g/50mL | B. Braun Medical Inc. | None |
| 0264-3450 | Piperacillin and Tazobactam and Sodium Chloride | injection, solution | 500 mg/100mL; 4 g/100mL | B. Braun Medical Inc. | None |
| 0338-9632 | Zosyn | injection, solution | 2 g/50mL; .25 g/50mL | Baxter Healthcare Corporation | None |
| 0206-8860 | Zosyn in Galaxy Containers | injection, solution | 250 mg/50mL; 2 g/50mL | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | None |
| 0338-9636 | Zosyn | injection, solution | 3 g/50mL; .375 g/50mL | Baxter Healthcare Corporation | None |
| 0206-8861 | Zosyn in Galaxy Containers | injection, solution | 375 mg/50mL; 3 g/50mL | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | None |
| 0338-9638 | Zosyn | injection, solution | 4 g/100mL; .5 g/100mL | Baxter Healthcare Corporation | None |
| 0206-8862 | Zosyn in Galaxy Containers | injection, solution | 500 mg/100mL; 4 g/100mL | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | None |
| 35369-0502 | Piperacillin and Tazobactam | injection, powder, for solution | 2 g/10mL; .25 g/10mL | Shandong Anxin Pharmaceutical Co., Ltd. | None |
| 60505-6156 | Piperacillin and Tazobactam | injection, powder, for solution | 2 g/10mL; .25 g/10mL | Apotex Corp. | None |
| 63323-309 | Piperacillin and Tazobactam | injection, powder, for solution | 2 g/10mL; .25 g/10mL | Fresenius Kabi USA, LLC | None |
| 63323-309 | Piperacillin and Tazobactam | injection, powder, for solution | 2 g/10mL; .25 g/10mL | Fresenius Kabi USA, LLC | None |
| 68001-506 | Piperacillin and Tazobactam | injection, powder, for solution | 2 g/10mL; .25 g/10mL | BluePoint Laboratories | None |
| 83270-301 | piperacillin and tazobactam | injection, powder, for solution | 2 g/10mL; .25 g/10mL | ONESOURCE SPECIALTY PHARMA LIMITED | None |
| 83634-104 | Piperacillin and Tazobactam | injection, powder, for solution | 2 g/10mL; .25 g/10mL | Avenacy, LLC | None |
| 44567-801 | Piperacillin and Tazobactam | injection, powder, for solution | 2 g/1; .25 g/1 | WG Critical Care, LLC | None |
| 35369-0503 | Piperacillin and Tazobactam | injection, powder, for solution | 3 g/15mL; .375 g/15mL | Shandong Anxin Pharmaceutical Co., Ltd. | None |
| 60505-6157 | Piperacillin and Tazobactam | injection, powder, for solution | 3 g/15mL; .375 g/15mL | Apotex Corp. | None |
| 63323-300 | Piperacillin and Tazobactam | injection, powder, for solution | 3 g/15mL; .375 g/15mL | Fresenius Kabi USA, LLC | None |
| 63323-300 | Piperacillin and Tazobactam | injection, powder, for solution | 3 g/15mL; .375 g/15mL | Fresenius Kabi USA, LLC | None |
| 68001-507 | Piperacillin and Tazobactam | injection, powder, for solution | 3 g/15mL; .375 g/15mL | BluePoint Laboratories | None |
| 72485-403 | piperacillin and tazobactam | injection, powder, for solution | 3 g/15mL; .375 g/15mL | Armas Pharmaceuticals Inc. | None |
| 72572-414 | piperacillin and tazobactam | injection, powder, for solution | 3 g/15mL; .375 g/15mL | Civica, Inc. | None |
| 72572-573 | Piperacillin and Tazobactam | injection, powder, for solution | 3 g/15mL; .375 g/15mL | Civica, Inc. | None |
| 83270-302 | piperacillin and tazobactam | injection, powder, for solution | 3 g/15mL; .375 g/15mL | ONESOURCE SPECIALTY PHARMA LIMITED | None |
| 83634-105 | Piperacillin and Tazobactam | injection, powder, for solution | 3 g/15mL; .375 g/15mL | Avenacy, LLC | None |
| 44567-802 | Piperacillin and Tazobactam | injection, powder, for solution | 3 g/1; .375 g/1 | WG Critical Care, LLC | None |
| 63323-304 | Piperacillin and Tazobactam | injection, powder, for solution | 36 g/180mL; 4.5 g/180mL | Fresenius Kabi USA, LLC | None |
| 63323-304 | Piperacillin and Tazobactam | injection, powder, for solution | 36 g/180mL; 4.5 g/180mL | Fresenius Kabi USA, LLC | None |
| 63323-304 | Piperacillin and Tazobactam | injection, powder, for solution | 36 g/180mL; 4.5 g/180mL | Fresenius Kabi USA, LLC | None |
| 65219-256 | Piperacillin and Tazobactam | injection, powder, for solution | 36 g/180mL; 4.5 g/180mL | Fresenius Kabi USA, LLC | None |
| 65219-256 | Piperacillin and Tazobactam | injection, powder, for solution | 36 g/180mL; 4.5 g/180mL | Fresenius Kabi USA, LLC | None |
| 65219-256 | Piperacillin and Tazobactam | injection, powder, for solution | 36 g/180mL; 4.5 g/180mL | Fresenius Kabi USA, LLC | None |
| 83634-112 | Piperacillin and Tazobactam | injection, powder, for solution | 36 g/180mL; 4.5 g/180mL | Avenacy, LLC | None |
| 44567-804 | Piperacillin and Tazobactam | injection, powder, for solution | 36 g/1; 4.5 g/1 | WG Critical Care, LLC | None |
| 44567-803 | Piperacillin and Tazobactam | injection, powder, for solution | 4 g/1; .5 g/1 | WG Critical Care, LLC | None |
| 35369-0501 | Piperacillin and Tazobactam | injection, powder, for solution | 4 g/20mL; .5 g/20mL | Shandong Anxin Pharmaceutical Co., Ltd. | None |
| 60505-6159 | Piperacillin and Tazobactam | injection, powder, for solution | 4 g/20mL; .5 g/20mL | Apotex Corp. | None |
| 63323-320 | Piperacillin and Tazobactam | injection, powder, for solution | 4 g/20mL; .5 g/20mL | Fresenius Kabi USA, LLC | None |
Showing 40 of 84 listings.
Questions
Is piperacillin and tazobactam a controlled substance?
No. Piperacillin and tazobactam is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and piperacillin and tazobactam is not on the DEA controlled substances list.
Is piperacillin and tazobactam a narcotic?
No. Piperacillin and tazobactam is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Penicillin-class Antibacterial and beta Lactamase Inhibitor.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Piperacillin and Tazobactam
- What is Piperacillin and Tazobactam used for?FDA label uses
- Generic for ZosynFDA Orange Book
- Penicillin-class Antibacterials listFDA drug class
- Beta Lactamase Inhibitors listFDA drug class
- NDC 0206-8860Piperacillin and Tazobactam NDC record
- NDC 0206-8861Piperacillin and Tazobactam NDC record
- NDC 0206-8862Piperacillin and Tazobactam NDC record